Tetra
Discovery is a Michigan-based biotechnology firm that develops compounds for the treatment of brain disorders associated with cognitive and memory deficits... Read moreTetra
Discovery is a Michigan-based biotechnology firm that develops compounds for the treatment of brain disorders associated with cognitive and memory deficits... Read more
Est. Annual Revenue
Est. Employees
News
Jul 18, 2024
Business Wire
Press Release: Tetra : Shionogi Provides Updates on Zatolmilast, an Investigational Drug for Fragile X Syndrome, Including Recent Changes to Study Protocol to Increase Access for Participants and Families
Sep 28, 2023
Pharamceutical Technology
Tetra: Tetra receives rare paediatric disease designation for FXS therapy
Jul 12, 2022
FirstWord Pharma
Tetra: Tetra Therapeutics Initiates Phase 2b/3 Clinical Studies of Investigational Drug BPN14770 in Fragile X Syndrome
Feb 14, 2021
MiBiz
Tetra Therapeutics: Tetra Therapeutics' Shionogi deal builds resources of large pharmaceutical company
Nov 02, 2020
Business Wire
Press Release: Tetra Therapeutics : Tetra Therapeutics Announces Positive Topline Results from Phase 2 Study of BPN14770 in Patients with Fragile X Syndrome
Jun 07, 2020
MiBiz
Tetra Therapeutics: 'TREMENDOUS WIN': Tetra Therapeutics' sale offers healthy returns for investors, validation for local ecosystem
May 28, 2020
Crain's Detroit Business
Tetra Therapeutics: Grand Rapids-based Tetra Therapeutics finalizes deal to sell to Japanese partner
May 26, 2020
M&A Times
Tetra Discovery: Shionogi acquires Tetra, a US drug research and development company
Mar 09, 2020
DBusiness Magazine
Tetra Discovery: Grand Rapids' Tetra Therapeutics Expands Alliance with Japan's Shionogi to Develop Treatment for Cognitive Impairment
Mar 09, 2020
PMLiVE
Tetra Discovery: Shionogi makes buyout play for Tetra ahead of Alzheimer's readout
